Dolutegravir Reduces Human T-Cell Lymphotropic Virus Type 1 Proviral Load and Improves Neurological Outcomes in a Phase 2 Controlled Trial.
Saved in:
| Title: | Dolutegravir Reduces Human T-Cell Lymphotropic Virus Type 1 Proviral Load and Improves Neurological Outcomes in a Phase 2 Controlled Trial. |
|---|---|
| Authors: | Brites C; Department of Medicine, School of Medicine, Federal University of Bahia, Salvador, Brazil.; Fundação Bahiana de Infectologia, Salvador, Brazil., Montaño-Castellon I; Fundação Bahiana de Infectologia, Salvador, Brazil., Arriaga MB; Fundação Bahiana de Infectologia, Salvador, Brazil., Marconi C; Department of Medicine, School of Medicine, Federal University of Bahia, Salvador, Brazil., Mayoral R; Fundação Bahiana de Infectologia, Salvador, Brazil., Luz E; Fundação Bahiana de Infectologia, Salvador, Brazil., Figueredo CA; Instituto de Ciências da Saude, Federal University of Bahia, Salvador, Brazil., Fiuza BSD; Instituto de Ciências da Saude, Federal University of Bahia, Salvador, Brazil., Netto EM; Department of Medicine, School of Medicine, Federal University of Bahia, Salvador, Brazil.; Fundação Bahiana de Infectologia, Salvador, Brazil. |
| Source: | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2026 May 20; Vol. 82 (5), pp. e910-e920. |
| Publication Type: | Journal Article; Randomized Controlled Trial; Clinical Trial, Phase II |
| Journal Info: | Publisher: Oxford University Press Country of Publication: United States NLM ID: 9203213 Publication Model: Print Cited Medium: Internet ISSN: 1537-6591 (Electronic) Linking ISSN: 10584838 NLM ISO Abbreviation: Clin Infect Dis Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 41834485 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Dolutegravir Reduces Human T-Cell Lymphotropic Virus Type 1 Proviral Load and Improves Neurological Outcomes in a Phase 2 Controlled Trial. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Brites+C%22">Brites C</searchLink>; Department of Medicine, School of Medicine, Federal University of Bahia, Salvador, Brazil.; Fundação Bahiana de Infectologia, Salvador, Brazil.<br /><searchLink fieldCode="AU" term="%22Montaño-Castellon+I%22">Montaño-Castellon I</searchLink>; Fundação Bahiana de Infectologia, Salvador, Brazil.<br /><searchLink fieldCode="AU" term="%22Arriaga+MB%22">Arriaga MB</searchLink>; Fundação Bahiana de Infectologia, Salvador, Brazil.<br /><searchLink fieldCode="AU" term="%22Marconi+C%22">Marconi C</searchLink>; Department of Medicine, School of Medicine, Federal University of Bahia, Salvador, Brazil.<br /><searchLink fieldCode="AU" term="%22Mayoral+R%22">Mayoral R</searchLink>; Fundação Bahiana de Infectologia, Salvador, Brazil.<br /><searchLink fieldCode="AU" term="%22Luz+E%22">Luz E</searchLink>; Fundação Bahiana de Infectologia, Salvador, Brazil.<br /><searchLink fieldCode="AU" term="%22Figueredo+CA%22">Figueredo CA</searchLink>; Instituto de Ciências da Saude, Federal University of Bahia, Salvador, Brazil.<br /><searchLink fieldCode="AU" term="%22Fiuza+BSD%22">Fiuza BSD</searchLink>; Instituto de Ciências da Saude, Federal University of Bahia, Salvador, Brazil.<br /><searchLink fieldCode="AU" term="%22Netto+EM%22">Netto EM</searchLink>; Department of Medicine, School of Medicine, Federal University of Bahia, Salvador, Brazil.; Fundação Bahiana de Infectologia, Salvador, Brazil. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%229203213%22">Clinical infectious diseases : an official publication of the Infectious Diseases Society of America</searchLink> [Clin Infect Dis] 2026 May 20; Vol. 82 (5), pp. e910-e920. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Randomized Controlled Trial; Clinical Trial, Phase II – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Oxford+University+Press%22">Oxford University Press </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>9203213 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1537-6591 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2210584838%22">10584838 </searchLink><i>NLM ISO Abbreviation: </i>Clin Infect Dis <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41834485 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1093/cid/ciag163 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: e910 Titles: – TitleFull: Dolutegravir Reduces Human T-Cell Lymphotropic Virus Type 1 Proviral Load and Improves Neurological Outcomes in a Phase 2 Controlled Trial. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Brites C – PersonEntity: Name: NameFull: Montaño-Castellon I – PersonEntity: Name: NameFull: Arriaga MB – PersonEntity: Name: NameFull: Marconi C – PersonEntity: Name: NameFull: Mayoral R – PersonEntity: Name: NameFull: Luz E – PersonEntity: Name: NameFull: Figueredo CA – PersonEntity: Name: NameFull: Fiuza BSD – PersonEntity: Name: NameFull: Netto EM IsPartOfRelationships: – BibEntity: Dates: – D: 20 M: 05 Text: 2026 May 20 Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 1537-6591 Numbering: – Type: volume Value: 82 – Type: issue Value: 5 Titles: – TitleFull: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America Type: main |
| ResultId | 1 |